I forwarded this to our pharmacists. They hadn't read it yet. Thank you, Tim, for sharing. We know this is a big problem based on our experiences, but having the ISMP issue an alert seems to be more valuable.

I love this group.

Gwen Irwin
Austin, Texas

----- Original Message ----- From: "Darnell Roth" <[EMAIL PROTECTED]> To: <[EMAIL PROTECTED]>; <[EMAIL PROTECTED]>; "Lynn Hadaway" <[EMAIL PROTECTED]>
Sent: Friday, August 11, 2006 8:11 AM
Subject: Re: Phenergan


about time -  couldn't be happier

Darnell Roth
----- Original Message ----- From: "Lynn Hadaway" <[EMAIL PROTECTED]>
To: <[EMAIL PROTECTED]>; <[EMAIL PROTECTED]>
Sent: Thursday, August 10, 2006 4:26 PM
Subject: Re: Phenergan


Hallelujah, this is long overdue!! Lynn

At 8:36 PM +0000 8/10/06, [EMAIL PROTECTED] wrote:
New as of today.

The ISMP Medication Safety Alert, August 10, 2006 - Volume 11 Issue 16.

The Institute for Safe Medication Practice.

Action needed to prevent serious tissue injury with IV promethazine.

"However, due to the frequency of severe, tragic, local injuries after
infiltration or inadvertent intra-arterial injection, ISMP recommends
that the FDA reexamine the product labeling and consider eliminating the
IV route of administration."

 Reference newspaper article:
http://www.thedailyworld.com/articles/2005/12/07/local_news/02news.txt

Please email me privately and I will send you the pdf newsletter as an
attachement.  This is pretty good material to stop the use of IV
Phenergan.


Timothy Royer, BSN, CRNI
Nurse Manager / Vascular Access / Diagnostic Service
VA Puget Sound Health Care System
Seattle / American Lake Divisions, WA


--
Lynn Hadaway, M.Ed., RNC, CRNI
Lynn Hadaway Associates, Inc.
126 Main Street, PO Box 10
Milner, GA 30257
http://www.hadawayassociates.com
office 770-358-7861




Reply via email to